Impact of milbemycin oxime on fluconazole resistance in <i>Candida auris</i>
Milbemycin oxime could represent an interesting adjunctive therapy against azole-resistant <i>C. auris</i>, particularly those with <i>CDR1</i> overexpression.
Authors
- Frédéric Lamoth (ORCID: https://orcid.org/0000-0002-1023-5597)
- Danielle Brandalise
- Dominique Sanglard (ORCID: https://orcid.org/0000-0002-5244-4178)
- Alix T. Coste (ORCID: https://orcid.org/0000-0001-9481-9778)
- Jizhou Li (ORCID: https://orcid.org/0000-0001-6007-2661)
- Lola Aubry
- Marine Louvet
Institutions
- Czech Academy of Sciences, Institute of Microbiology (CZ)
- University of Lausanne (CH)
Publication Details
- Journal
- JAC-Antimicrobial Resistance
- Published
- 2025-03-04
- DOI
- https://doi.org/10.1093/jacamr/dlaf060
- Citations
- 1
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Fondation pour la Recherche Médicale
- Fondation Santos-Suarez pour la Recherche Médicale